Bachmann G, Su J, Zumegen C, Wittekindt C, Michel O
Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Universität zu Köln.
HNO. 2001 Jul;49(7):538-42. doi: 10.1007/s001060170078.
Prednisolone is the drug of first choice for the treatment of cochleovestibular disorders, such as sudden hearing loss. Because of the known side effects, the efficient drug levels to be achieved within inner ear fluids are limited by intravenous administration. The aim of the study was to determine the concentration in the perilymph of prednisolone-21-hydrogen succinate applied into the round window niche in comparison to the concentration after intraperitoneal application.
Application of prednisolone-21-hydrogen succinate (5 mg in 0.1 ml) on the round window membrane was performed after sedation under microscopic view directly into the round window niche of the guinea pig. In order to compare the results, perilymph samples after systemic application of 60 mg/kg body weight prednisolone were used. The time between application and taking specimens of perilymph from the cochlea varied. Specimens of perilymph were obtained after 15, 20, 80, 180, 330, and 960 min (10 specimens in each group, n = 60) by dissecting the cochlea and opening the apex cochleae. Levels of prednisolone-21-hydrogen succinate in perilymph were measured by isocratic high-pressure liquid chromatography (HPLC).
The highest levels of prednisolone-21-hydrogen succinate were found after 180 min: 952.3 mg/l (95% confidence interval: 382.7). After 960 min the level was 18.72 mg/l (95% confidence interval: 16.9). In the group with systemic application, the levels measured were below 14.71 mg/l (95% confidence interval: 7.05).
The results demonstrate that high levels of prednisolone-21-hydrogen succinate in perilymph are achievable by local application of a single dose into the round window niche. After application of 5 mg, the levels of prednisolone are measurable up to 16 h.
泼尼松龙是治疗耳蜗前庭疾病(如突发性听力损失)的首选药物。由于已知的副作用,通过静脉给药在内耳液中达到有效药物水平受到限制。本研究的目的是比较将琥珀酸氢化泼尼松龙应用于圆窗龛后与腹腔注射后在内淋巴中的浓度。
在麻醉下于显微镜直视下将琥珀酸氢化泼尼松龙(5mg溶于0.1ml)直接应用于豚鼠的圆窗膜上的圆窗龛。为了比较结果,使用全身应用60mg/kg体重泼尼松龙后的内淋巴样本。从给药到从耳蜗采集内淋巴样本的时间各不相同。在15、20、80、180、330和960分钟后(每组10个样本,n = 60),通过解剖耳蜗并打开耳蜗顶端获取内淋巴样本。通过等度高压液相色谱法(HPLC)测量内淋巴中琥珀酸氢化泼尼松龙的水平。
在180分钟后发现琥珀酸氢化泼尼松龙的最高水平:952.3mg/l(95%置信区间:382.7)。在960分钟后水平为18.72mg/l(95%置信区间:16.9)。在全身应用组中,测量的水平低于14.71mg/l(95%置信区间:7.05)。
结果表明,通过向圆窗龛局部单次给药可在内淋巴中实现高浓度的琥珀酸氢化泼尼松龙。应用5mg后,泼尼松龙水平在长达16小时内均可测量。